Pharmaceutical News

RSS

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.

19 Nov 2012

KemPharm announces successful Type B meeting with FDA for KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.

19 Nov 2012

GVK Biosciences receives AERB approvals to carry out 3H and 14C synthesis activities

GVK Biosciences, Asia's leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities.

19 Nov 2012

Zolpidem associated with increased risk of falls

A drug commonly prescribed to help patients sleep in hospitals has been associated with an increased risk of falls, according to a study published in the Journal of Hospital Medicine.

19 Nov 2012

FDA accepts Orexo’s Zubsolv NDA for review

FDA has informed Orexo that the Zubsolv New Drug Application (NDA) has been accepted for review, and that the Prescription Drug User Fee Act (PDUFA) action date will be July 6, 2013.

19 Nov 2012

Marinomed’s Antiviral polymer awarded Chinese patent

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, today announced that it has been granted Chinese Patent No. CN101678040, entitled 'Antiviral polymer', by the Chinese patent office.

18 Nov 2012

Summit looks at the growing problem of prescription drug abuse

Today, a not-for-profit organization presenting at the Delaware Prescription Drug Abuse Summit appealed to the event's host, Attorney General Beau Biden, for assistance in preventing medication overdoses.

17 Nov 2012

MusculoskeletalNetwork features special coverage of sessions from ACR annual meeting

UBM Medica US announces that MusculoskeletalNetwork features special coverage of sessions from the annual meeting of the American College of Rheumatology (ACR), including the latest information about new FDA processes for approval of biosimilars that are like generic versions of expensive medications now used to treat painful rheumatologic conditions such as rheumatoid arthritis (RA).

17 Nov 2012

Personality traits linked with individual's susceptibility to placebo effect from pain medicines

Personality traits might do more than help you win a popularity contest. According to new University of Michigan-led neuroscience research, co-authored by University of Maryland (UM) School of Dentistry Dean Christian S. Stohler, DMD, DrMedDent, such traits also might make you more likely to get pain relief from a placebo - a fake medicine.

17 Nov 2012

HCV medications' side effects can now be replicated and observed in Petri dishes and test tubes

The adverse side effects of certain hepatitis C medications can now be replicated and observed in Petri dishes and test tubes, thanks to a research team led by Craig Cameron, the Paul Berg Professor of Biochemistry and Molecular Biology at Penn State University.

17 Nov 2012

Study reveals significant regional variation and trends in antibiotic use between 1999-2010

Research revealed during "Get Smart Week" shows that California joined Alaska, Hawaii, Oregon and Washington as the five states with the lowest antibiotic use in the nation in 2010.

17 Nov 2012

Study examines public health impact of tamper resistant extended-release oxycodone

This is the first epidemiological study to examine the public health impact of a tamper resistant extended-release oxycodone (ORF). ER oxycodone was reformulated with physicochemical barriers to crushing and dissolving intended to reduce abuse through non-oral routes of administration.

16 Nov 2012

Arginine and proline supplementation favor wound healing in diabetic rats

Chronic wounds such as foot ulcers are a common problem for diabetics and are the cause of more than 80 percent of the lower leg amputations in these patients. There is currently no effective way to improve healing of these types of wounds, but new research offers hope.

16 Nov 2012

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.

16 Nov 2012

Vaccinating families could protect young babies against RSV infection

Research by the University of Warwick indicates that vaccinating families could protect young babies against a common winter virus which can be fatal for infants under six months.

16 Nov 2012

Meningitis vaccine declared usable without refrigeration for up to four days

"In a breakthrough for the fight against meningitis in poor countries, researchers say the WHO has ruled that a key vaccine can be transported or stored for up to four days without refrigeration," Agence France-Presse reports.

16 Nov 2012

D737 compound restores motor function and longevity in fruit flies with Alzheimer's

An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.

16 Nov 2012

FDA chief's call for greater oversight of drug compounders triggers Republican skepticism

Members of the House Energy and Commerce Committee Wednesday questioned Food and Drug Administration head Margaret Hamburg and the co-owner of a compounding pharmacy linked with a deadly meningitis outbreak. Hamburg called for Congress to give the FDA greater oversight of compounding pharmacies, which was met with skepticism by Republican lawmakers.

16 Nov 2012

Expert panel confirms safety of calcium supplements in relation to cardiovascular disease

Individuals who do not obtain recommended intake levels of calcium through dietary sources can safely utilize calcium supplements to achieve optimal bone health, an expert panel concludes.

16 Nov 2012

High risk CVD patients more likely to receive prescriptions for cholesterol-lowering drugs

In a new study, Northwestern Medicine researchers found that patients at high risk for cardiovascular disease (CVD) are more likely to receive a prescription for cholesterol-lowering medication, and to achieve lower long-term cholesterol levels, when doctors use electronic health records (EHRs) to deliver personalized risk assessments via mail.

16 Nov 2012

Pharmaceutical News

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

KemPharm announces successful Type B meeting with FDA for KP201

GVK Biosciences receives AERB approvals to carry out 3H and 14C synthesis activities

Zolpidem associated with increased risk of falls

FDA accepts Orexo’s Zubsolv NDA for review

Marinomed’s Antiviral polymer awarded Chinese patent

Summit looks at the growing problem of prescription drug abuse

MusculoskeletalNetwork features special coverage of sessions from ACR annual meeting

Personality traits linked with individual's susceptibility to placebo effect from pain medicines

HCV medications' side effects can now be replicated and observed in Petri dishes and test tubes

Study reveals significant regional variation and trends in antibiotic use between 1999-2010

Study examines public health impact of tamper resistant extended-release oxycodone

Arginine and proline supplementation favor wound healing in diabetic rats

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

Vaccinating families could protect young babies against RSV infection

Meningitis vaccine declared usable without refrigeration for up to four days

D737 compound restores motor function and longevity in fruit flies with Alzheimer's

FDA chief's call for greater oversight of drug compounders triggers Republican skepticism

Expert panel confirms safety of calcium supplements in relation to cardiovascular disease

High risk CVD patients more likely to receive prescriptions for cholesterol-lowering drugs

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News